|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
GlaxoSmithKline (ГлаксоСмитКлайн)
Main Activities: Scientific Research and Development Services - Drugs and Druggists' Sundries Merchant Wholesalers
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name GlaxoSmithKline (ГлаксоСмитКлайн ЕООД) Legal Address 10, Dimitar Manov Str.; Sofia; Sofia - city; 1408 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational BG VAT Identification Code: BG131159254 BULSTAT: 131159254 Financial Auditors: PricewaterhouseCoopers (2011) Total Employees: 199 Tel: (+359 2) 953 10 34 |
|
Company Description |
| GlaxoSmithKline, which was established in 2003, is a part of British GlaxoSmithKline Group. The Bulgarian arm is active in medical research and wholesale of pharmaceuticals. In 2004, the company opened a BGN 5 million distribution center in Sofia. |
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues increased with 31.15%, from BGN 94,973 thousands to BGN 124,561 thousands. Operating result increased from BGN 3,333 thousands to BGN 4,907 thousands which means 47.22% change. The results of the period increased 48.73% reaching BGN 4,273 thousands at the end of the period against BGN 2,873 thousands last year. Return on equity (Net income/Total equity) went from 11.52% to 14.63%, the Return On Asset (Net income / Total Asset) went from 5.78% to 6.51% and the Net Profit Margin (Net Income/Net Sales) went from 3.03% to 3.43% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 124.62% compared to 99.36% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.95 to 1.75 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| ISI Financial Statements | ISI Financial Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
65,599 |
49,704 |
| ||
Current Assets |
XX,XXX |
XX,XXX |
| ||
Total Liabilities |
XX,XXX |
XX,XXX |
| ||
Shareholders Equity |
XX,XXX |
XX,XXX |
| ||
Current Liabilities |
XX,XXX |
XX,XXX |
| ||
| * All the accounts are in BGN. | ||
Income Statement
| ||
Total Operating Revenue |
XXX,XXX |
XX,XXX |
| ||
Operational Profit (Loss) |
X,XXX |
X,XXX |
| ||
Net Profit (Loss) |
X,XXX |
X,XXX |
| ||
| * All the accounts are in BGN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
X.XX% |
X.XX% |
| ||
Annualised Return on Assets (ROA) |
X.XX% |
X.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Return on Sales (ROS) |
X.XX% |
X.XX% |
| ||
Return on Capital |
XX.XX% |
XX.XX% |
| ||
Gross Profit Margin |
XX.XX% |
XX.XX% |
| ||
Operating Profit Margin |
X.XX% |
X.XX% |
| Efficiency Ratios | ||
| ||
Inventory Turnover |
X.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
XX.XXx |
XX.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
X,XXX |
X,XXX |
| ||
EBITDA |
X,XXX |
X,XXX |
| ||
Bookvalue (BV) |
XX,XXX |
XX,XXX |
| ||
Net Cash |
-XX,XXX |
-XX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.XX% |
| ||
Quick ratio |
XX.XX% |
XXX.XX% |
| ||
Doom's day ratio |
XX.XX% |
XX.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Debt to equity |
XXX.XX% |
XX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| ||
Long Term Debt to Capital |
X.XX% |
X.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX.XX% |
XXX.XX% |
| ||
Net Income Trend |
XXX.XX% |
XXX.XX% |
| ||
Operating Income Trend |
XXX.XX% |
XXX.X% |
| ||
 |